J G Gerber

1.6k total citations
47 papers, 1.2k citations indexed

About

J G Gerber is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Biochemistry. According to data from OpenAlex, J G Gerber has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 11 papers in Biochemistry. Recurrent topics in J G Gerber's work include Neuropeptides and Animal Physiology (11 papers), Eicosanoids and Hypertension Pharmacology (10 papers) and Inflammatory mediators and NSAID effects (10 papers). J G Gerber is often cited by papers focused on Neuropeptides and Animal Physiology (11 papers), Eicosanoids and Hypertension Pharmacology (10 papers) and Inflammatory mediators and NSAID effects (10 papers). J G Gerber collaborates with scholars based in United States, Sweden and Germany. J G Gerber's co-authors include Alan S. Nies, N A Payne, David Wyles, J. Gál, John W. Hollifield, John Τ. Reeves, N. F. Voelkel, Ivan F. McMurtry, Joann L. Data and William J. Crump and has published in prestigious journals such as Journal of Clinical Investigation, Circulation Research and The Journal of Physiology.

In The Last Decade

J G Gerber

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J G Gerber United States 20 281 237 232 220 216 47 1.2k
John F. Gerkens Australia 23 391 1.4× 157 0.7× 285 1.2× 233 1.1× 240 1.1× 54 1.4k
W P Leary South Africa 19 87 0.3× 290 1.2× 153 0.7× 72 0.3× 218 1.0× 82 1.5k
Diane K. Jorkasky United States 27 144 0.5× 425 1.8× 138 0.6× 87 0.4× 341 1.6× 68 1.7k
Mack C. Mitchell United States 28 111 0.4× 87 0.4× 255 1.1× 191 0.9× 359 1.7× 77 2.6k
Eric Pussard France 23 118 0.4× 239 1.0× 161 0.7× 57 0.3× 285 1.3× 96 1.6k
Ramón Vargas United States 20 275 1.0× 229 1.0× 139 0.6× 35 0.2× 218 1.0× 60 1.4k
Hiroshi Takane Japan 23 164 0.6× 197 0.8× 173 0.7× 29 0.1× 468 2.2× 71 1.8k
E. E. Ohnhaus Switzerland 20 113 0.4× 106 0.4× 82 0.4× 58 0.3× 174 0.8× 62 1.1k
Shin Irie Japan 24 213 0.8× 187 0.8× 124 0.5× 40 0.2× 289 1.3× 89 1.9k
Patricia Compagnon France 17 93 0.3× 479 2.0× 268 1.2× 33 0.1× 315 1.5× 37 1.2k

Countries citing papers authored by J G Gerber

Since Specialization
Citations

This map shows the geographic impact of J G Gerber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J G Gerber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J G Gerber more than expected).

Fields of papers citing papers by J G Gerber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J G Gerber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J G Gerber. The network helps show where J G Gerber may publish in the future.

Co-authorship network of co-authors of J G Gerber

This figure shows the co-authorship network connecting the top 25 collaborators of J G Gerber. A scholar is included among the top collaborators of J G Gerber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J G Gerber. J G Gerber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Glesby, Marshall J., Judith A. Aberg, Michelle A. Kendall, et al.. (2005). Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers. Clinical Pharmacology & Therapeutics. 78(2). 143–153. 69 indexed citations
3.
Wyles, David & J G Gerber. (2004). Antiretroviral Drug Pharmacokinetics in Hepatitis with Hepatic Dysfunction. Clinical Infectious Diseases. 40(1). 174–181. 56 indexed citations
4.
Gerber, J G, et al.. (1999). Lack of an Effect of Age on  -Adrenoceptor--Mediated Lipolysis in Isolated Human Adipocytes. The Journals of Gerontology Series A. 54(2). B71–B77. 10 indexed citations
5.
Gerber, J G, et al.. (1998). The Effect of Adenosine on the Reduced Heart Rate Response to Exercise in the Elderly. The Journals of Gerontology Series A. 53A(2). M87–M91. 1 indexed citations
6.
Gál, J., et al.. (1998). Neither dapsone hydroxylation nor cortisol 6β-hydroxylation detects the inhibition of CYP3A4 by HIV-1 protease inhibitors. European Journal of Clinical Pharmacology. 54(9-10). 741–747. 31 indexed citations
7.
Gál, J., et al.. (1996). The effect of aging on the pharmacokinetics and pharmacodynamics of prazosin. European Journal of Clinical Pharmacology. 50(1-2). 41–46. 24 indexed citations
8.
Gerber, J G & N A Payne. (1995). The role of gastric histamine release in the acid secretory response to pentagastrin and methacholine in the dog. Inflammation Research. 44(8). 327–334. 4 indexed citations
9.
Gál, J., et al.. (1992). Age and gender influence the stereoselective pharmacokinetics of propranolol.. Journal of Pharmacology and Experimental Therapeutics. 261(3). 1181–1186. 50 indexed citations
10.
Payne, N A & J G Gerber. (1992). Differential effects of somatostatin and prostaglandins on gastric histamine release to pentagastrin.. Journal of Pharmacology and Experimental Therapeutics. 263(2). 520–526. 8 indexed citations
11.
Gerber, J G, et al.. (1989). Atrial natriuretic peptide blocks the renal vasoconstrictor response to hypertonic saline in the dog.. Journal of Pharmacology and Experimental Therapeutics. 251(1). 77–81. 3 indexed citations
12.
Gerber, J G & N A Payne. (1988). Endogenous adenosine modulates gastric acid secretion to histamine in canine parietal cells.. Journal of Pharmacology and Experimental Therapeutics. 244(1). 190–194. 19 indexed citations
13.
Balazy, Michael, Eric P. Brass, J G Gerber, & Alan S. Nies. (1988). Facile method for preparation of 2,3-dinor-6-keto PGF1α, the major urinary metabolite of prostacyclin. Prostaglandins. 36(4). 421–430. 12 indexed citations
14.
Zahniser, Nancy R., David C. Parker, Carol M. Bier‐Laning, et al.. (1988). Comparison Between the Effects of Aging on Antagonist and Agonist Interactions With Beta-Adrenergic Receptors on Human Mononuclear and Polymorphonuclear Leukocyte Membranes. Journal of Gerontology. 43(6). M151–M157. 6 indexed citations
15.
Gerber, J G. (1988). Is the parietal cell the major source of gastric mucosal prostaglandin E2?. Prostaglandins. 36(5). 581–583. 2 indexed citations
16.
Gerber, J G, et al.. (1984). Adenosine: a modulator of gastric acid secretion in vivo.. Journal of Pharmacology and Experimental Therapeutics. 231(1). 109–113. 25 indexed citations
17.
Nies, Alan S., et al.. (1982). Beta adrenergically mediated release of renin in the dog is not confined to either beta-1 or beta-2 adrenoceptors.. Journal of Pharmacology and Experimental Therapeutics. 222(3). 606–611. 5 indexed citations
18.
Nies, Alan S., et al.. (1981). Alpha adrenergic-mediated renin release is prostaglandin-dependent.. Journal of Pharmacology and Experimental Therapeutics. 219(2). 321–325. 16 indexed citations
19.
Villeneuve, J P, et al.. (1979). Drug metabolism in rats bearing a pituitary mammotropic tumor.. Journal of Pharmacology and Experimental Therapeutics. 209(1). 7–11. 8 indexed citations
20.
Gerber, J G & Alan S. Nies. (1979). The hemodynamic effects of prostaglandins in the rat. Evidence for important species variation in renovascular responses.. Circulation Research. 44(3). 406–410. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John F. Gerkens Breakdown of academic impact, for papers by W P Leary Breakdown of academic impact, for papers by Diane K. Jorkasky Breakdown of academic impact, for papers by Mack C. Mitchell Breakdown of academic impact, for papers by Eric Pussard Breakdown of academic impact, for papers by Ramón Vargas Breakdown of academic impact, for papers by Hiroshi Takane Breakdown of academic impact, for papers by E. E. Ohnhaus Breakdown of academic impact, for papers by Shin Irie Breakdown of academic impact, for papers by Patricia Compagnon
Rankless by CCL
2026